CN1923266A - Leukoderma treating medicine - Google Patents
Leukoderma treating medicine Download PDFInfo
- Publication number
- CN1923266A CN1923266A CN 200510017937 CN200510017937A CN1923266A CN 1923266 A CN1923266 A CN 1923266A CN 200510017937 CN200510017937 CN 200510017937 CN 200510017937 A CN200510017937 A CN 200510017937A CN 1923266 A CN1923266 A CN 1923266A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- root
- weight ratio
- angelicae sinensis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating leucodermia, which is prepared from the following raw materials (by weight ratio): Chinese angelica root 10-20, white atractylodes rhizome 10-20, pseudostellaria root 10-15, ledebouriella root 10-20, seed of Job's tears 15-30, chenopodium album 15-25, alkanna tinctoria 10-20, safflower 15-25, astragalus root 15-25, fleece-flower root 10-18, and licorice root 5-15. The preparation comprises steps of screening, washing, processing, drying, disintegrating, sieving and loading into capsules.
Description
(1) technical field
The present invention is the leukodermic medicine of a kind of treatment dermatosis, belongs to the field of Chinese medicines.
(2) background technology
Vitiligo is a kind of agnogenic dermatosis.For also neither one unified understanding of vitiligo, therefore, on Therapeutic Method, also all have nothing in common with each other at present.Generally adopt medicine to add the method for irradiation clinically, for example: 8-oxygen psoralen is the leukodermic oral drugs of a kind of treatment, and the back of taking medicine receives the irradiation of long wave ultraviolet, what have grows the pigment island in white macula, can continue treatment,, then need the defat treatment if do not have.Be 2-3 month the general course of treatment.The Chinese traditional treatment typing differs, and curative effect is difficult to control, easily recurrence.
(1) summary of the invention
The object of the invention provides a kind ofly can treat leukodermic Chinese medicine.
The composition of medicine of the present invention is made of by weight following medicine:
Radix Angelicae Sinensis 10-20, Rhizoma Atractylodis Macrocephalae 10-20, Radix Pseudostellariae 1015, Radix Saposhnikoviae 10-20, raw pearl barley 15-30, Fructus Atriplicis Sibiricae 15-25, Radix Arnebiae (Radix Lithospermi) 10-20, Flos Carthami 15-25, Radix Astragali 15-25, Radix Polygoni Multiflori 10-18, Radix Glycyrrhizae 5-15.
The weight ratio that said medicine is formed is preferably: Radix Angelicae Sinensis 15, the Rhizoma Atractylodis Macrocephalae 15, Radix Pseudostellariae 12, Radix Saposhnikoviae 15, raw pearl barley 20, Fructus Atriplicis Sibiricae 20, Radix Arnebiae (Radix Lithospermi) 15, Flos Carthami 20, Radix Astragali 20, Radix Polygoni Multiflori 12, Radix Glycyrrhizae 8.
Medicine of the present invention can be sent out method according to the preparation of routine and be prepared into the common drug dosage form.
The preparation method of medicine capsule of the present invention is:
Choose Chinese crude drug by the said medicine composition, screening is cleaned, and concocts, and drying is pulverized, and sieves, and is encapsulated.
Medicine of the present invention has QI and blood regulating, and replenishing QI to invigorate the spleen dispels the wind and moves back speckle, and the function of granulation promoting skin care cures mainly vitiligo, various pigmented spots, freckle, chloasma, butterfly spot, diseases such as cicatrix.
(4) specific embodiment
Drug therapy vitiligo of the present invention and all kinds of skin speckle disease are remarkably productive, now clinical application effect are summarized as follows:
Since year March in March, 1996 to 1999, with Drug therapy of the present invention vitiligo and dissimilar skin pigment spots, accumulative total has been accepted 820 routine patients for medical treatment, has carried out treatment and has observed.Proved that medicine of the present invention has original curative effect to all kinds of dermatosiss, also brought the convenience of taking medicine simultaneously, and produced good social benefit and economic benefit to the patient.Curative effect is summed up and is seen the following form:
The clinical efficacy summary sheet
| The sick kind | Case load | Cure | Produce effects | Effectively | Invalid | Effective percentage |
| Vitiligo and pigmented spots | 820 | 514 | 216 | 72 | 18 | 97.6％ |
Embodiment
The medicine composition: Radix Angelicae Sinensis 15 restrains, the Rhizoma Atractylodis Macrocephalae 15 restrains, Radix Pseudostellariae 12 restrains, Radix Saposhnikoviae 15 restrains, raw pearl barley 20 restrains, Fructus Atriplicis Sibiricae 20 restrains, Radix Arnebiae (Radix Lithospermi) 15 restrains, Flos Carthami 20 restrains, Radix Astragali 20 restrains, Radix Polygoni Multiflori 12 restrains, Radix Glycyrrhizae 8 restrains,
Choose medicine by above-mentioned composition, screening, cleaning, drying are pulverized, and cross 100 mesh sieves, and are encapsulated.
Claims (2)
1. treat leukodermic medicine for one kind, it is characterized in that it is to be made by the Chinese medicine of following weight ratio, Radix Angelicae Sinensis 10-20, Rhizoma Atractylodis Macrocephalae 10-20, Radix Pseudostellariae 10-15, Radix Saposhnikoviae 10-20, raw pearl barley 15-30, Fructus Atriplicis Sibiricae 15-25, Radix Arnebiae (Radix Lithospermi) 10-20, Flos Carthami 15-25, Radix Astragali 15-25, Radix Polygoni Multiflori 10-18, Radix Glycyrrhizae 5-15; Choose Chinese crude drug by the said medicine composition, screening is cleaned, and concocts, and drying is pulverized, and sieves, and is encapsulated.
2. the leukodermic medicine of a kind of treatment according to claim 1 is characterized in that the weight ratio that said medicine is formed is Radix Angelicae Sinensis 15, the Rhizoma Atractylodis Macrocephalae 15, Radix Pseudostellariae 12, Radix Saposhnikoviae 15, raw pearl barley 20, Fructus Atriplicis Sibiricae 20, Radix Arnebiae (Radix Lithospermi) 15, Flos Carthami 20, Radix Astragali 20, Radix Polygoni Multiflori 12, Radix Glycyrrhizae 8.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510017937 CN1923266A (en) | 2005-08-30 | 2005-08-30 | Leukoderma treating medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510017937 CN1923266A (en) | 2005-08-30 | 2005-08-30 | Leukoderma treating medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1923266A true CN1923266A (en) | 2007-03-07 |
Family
ID=37816209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510017937 Pending CN1923266A (en) | 2005-08-30 | 2005-08-30 | Leukoderma treating medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1923266A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102178764A (en) * | 2011-04-15 | 2011-09-14 | 谭进超 | Traditional Chinese medicine preparation capable of effectively repairing striae of pregnancy and scars |
-
2005
- 2005-08-30 CN CN 200510017937 patent/CN1923266A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102178764A (en) * | 2011-04-15 | 2011-09-14 | 谭进超 | Traditional Chinese medicine preparation capable of effectively repairing striae of pregnancy and scars |
| CN102178764B (en) * | 2011-04-15 | 2012-11-07 | 谭进超 | Traditional Chinese medicine preparation capable of effectively repairing striae of pregnancy and scars |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1739774A (en) | Spot eliminating and youthful looks preserving capsule | |
| CN100421717C (en) | A Chinese medicine for treating leukemia | |
| CN102266488B (en) | Medicament for treating leucoderma | |
| CN1814139A (en) | Baidianling capsule | |
| CN103356772B (en) | Medicament used for treating chloasma | |
| CN1060391C (en) | Traditional Chinese medicine for treating gynecological tumour | |
| CN1082376C (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
| CN109248305A (en) | A kind of Chinese medicine composition and preparation method thereof for treating liver fibrosis | |
| CN101926857A (en) | Traditional Chinese medicinal liniment for treating vitiligo | |
| CN1883642A (en) | Medicine for treating mammary glands hyperplasia | |
| CN1041495C (en) | External application medicine for curing hepatic disease | |
| CN1923266A (en) | Leukoderma treating medicine | |
| CN1111031C (en) | Medicine for treating leukoderma | |
| CN101979035A (en) | Medicament for treating gynecological abnormal leucorrhea | |
| CN1273847A (en) | Chinese medicine for treating dermatopathy | |
| CN104398975A (en) | Traditional Chinese medicinal preparation for treating fibroadenoma of breast and preparation method thereof | |
| CN111388564B (en) | Traditional Chinese medicine for treating bradyarrhythmia | |
| CN102430026A (en) | Medicine for removing macula | |
| CN103341108B (en) | Pharmaceutical composite for treating stress urinary incontinence after prostatectomy | |
| CN1219540C (en) | Chinese medicine for treating leukoderma and the prepn process of the tablets | |
| CN102743580B (en) | Traditional Chinese medicine pill for treating vitligo | |
| CN103301372B (en) | Preparation method of umbilicus dressing agent for treating post-operation prostate stress urinary incontinence | |
| CN101874861B (en) | Medicament for treating and preventing heart diseases | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN101940624A (en) | Chinese medicinal lotion for treating vitiligo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |